Correlation of the New York Heart Association Classification and the Cardiopulmonary Exercise Test: A Systematic Review
Overview
Affiliations
Aims: The New York Heart Association (NYHA) classification is frequently used in the management of heart failure but may be limited by patient and physician subjectivity. Cardiopulmonary exercise testing (CPET) provides a potentially more objective measurement of functional status. We aim to study the correlation between NYHA classification and peak oxygen consumption (pVO) on Cardiopulmonary Exercise Testing (CPET) within and across published studies.
Methods And Results: A systematic literature review on all studies reporting both NYHA class and CPET data was performed, and pVO from CPET was correlated to reported NYHA class within and across eligible studies. 38 studies involving 2645 patients were eligible. Heterogenity was assessed by the Q statistic, which is a χ2 test and marker of systematic differences between studies. Within each NYHA class, significant heterogeneity in pVO was seen across studies: NYHA I (n = 17, Q = 486.7, p < 0.0001), II (n = 24, Q = 381.0, p < 0.0001), III (n = 32, Q = 761.3, p < 0.0001) and IV (n = 5, Q = 12.8, p = 0.012). Significant differences in mean pVO were observed between NYHA I and II (23.8 vs 17.6 mL/(kg·min), p < 0.0001) and II and III (17.6 vs 13.3 mL/(kg·min), p < 0.0001); but not between NYHA III and IV (13.3 vs 12.5 mL/(kg·min), p = 0.45). These differences remained significant after adjusting for age, gender, ejection fraction and region of study.
Conclusion: There was a general inverse correlation between NYHA class and pVO However, significant heterogeneity in pVO exists across studies within each NYHA class. While the NYHA classification holds clinical value in heart failure management, direct comparison across studies may have its limitations.
Kwast S, Hoffmann J, Pokel C, Falz R, Schulze A, Schroter T Sci Rep. 2025; 15(1):8940.
PMID: 40089637 DOI: 10.1038/s41598-025-94172-1.
Sista A, Troxel A, Tarpey T, Parpia S, Goldhaber S, Stringer W Am Heart J. 2024; 281:112-122.
PMID: 39638275 PMC: 11810573. DOI: 10.1016/j.ahj.2024.11.016.
A scoping review on advancements in noninvasive wearable technology for heart failure management.
Scholte N, van Ravensberg A, Shakoor A, Boersma E, Ronner E, de Boer R NPJ Digit Med. 2024; 7(1):279.
PMID: 39396094 PMC: 11470936. DOI: 10.1038/s41746-024-01268-5.
Sakaguchi M, Miyai N, Kobayashi H, Arita M Eur Geriatr Med. 2023; 15(2):361-370.
PMID: 38147270 DOI: 10.1007/s41999-023-00905-8.
Neo S, Tan J, Sim D, Ng E, Loh J, Yang G Palliat Med Rep. 2022; 3(1):287-295.
PMID: 36479550 PMC: 9712046. DOI: 10.1089/pmr.2022.0029.